Amoeba (LTS:0RAE) Total Receivables: €0.11 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RAE Amoeba SA LTS:0RAE
28 GF Score
Price €0.76
! 3 Warning Signs
View Full Analysis

What is Amoeba Total Receivables?

Amoeba LTS:0RAE 28 Total Receivables is €0.11 Mil as of Dec. 2025. GuruFocus rates LTS:0RAE with a GF Score™ of 28/100. The stock has 3 warning signs investors should review.

Amoeba's Total Receivables for the quarter that ended in Dec. 2025 was €0.11 Mil.


Amoeba Total Receivables Historical Data

* Premium members only.

The historical data trend for Amoeba's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amoeba Total Receivables Chart

Amoeba Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.01 0.03 0.06 0.11

Amoeba Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.00 0.06 0.11 0.11
LTS:0RAE
28GF Score
Amoeba SA LTS:0RAE
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amoeba Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of €0.11 Mil mean?
Amoeba (LTS:0RAE) has a Total Receivables of €0.11 Mil as of Dec. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Amoeba and its competitors.
Is Amoeba's Total Receivables too high?
Amoeba's current Total Receivables is €0.11 Mil. Overall, Amoeba has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Amoeba's Total Receivables compare to CTVA and CF?
Amoeba's Total Receivables of €0.11 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for an Agriculture company?
A good Total Receivables depends on the Agriculture industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Amoeba and its competitors. Amoeba's current Total Receivables is €0.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amoeba stock overvalued right now?
Amoeba (LTS:0RAE) has a current Total Receivables of €0.11 Mil. The current Total Receivables is €0.11 Mil. Amoeba's overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Amoeba (LTS:0RAE), the current Total Receivables is €0.11 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Amoeba Business Description

Other Exchanges ALMIB:FranceA1H:Germany
Address 38 Avenue des Freres Montgolfier, Chassieu, Lyon, FRA, 69680
Amoeba SA is a France-based company engaged in developing, producing, and commercializing a biological biocide for use in the industrial sector. It develops Biomeba, a green biocide that harnesses the biocidal properties of Willaertia magna, which is used to treat cooling towers.
28GF Score

Get the complete analysis for LTS:0RAE

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.76
Price